Clinical Trial Imaging Market Analysis, Size, Growth, Share & Forecast to 2026 | Grand View Research Inc.
“Clinical Trial Imaging Market Worth $1.31 Billion by 2026 | CAGR: 5.8%�
The global clinical trial imaging market size is expected to reach USD 1.31 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.8% during the forecast period. Increasing spending on research and development activities to develop new drugs and therapies to treat chronic diseases is boosting market growth. Clinical trials assist in the development, registration, and eventually access of new drugs to patients. Imaging helps in the process of drug development by offering non-invasive evaluation of drug action and response of tumor to treatment. Functional imaging techniques are progressively being used in early phases of clinical trials to study initial effects of drug action on parts of tumor biology including metabolism, cellularity, and vascularity. Contract Research Organizations (CROs) were the most prominent end-use segment in the market in 2017. Imaging modalities are used to determine indicators of pharmacological response to a therapy. Biomarkers and surrogate endpoints assist in obtaining quick results with good statistical power even in small sample sizes encouraging CROs to carryout multiple studies with reduced cost of operation.
The market in Asia Pacific is projected to witness swift growth during the forecast period as the number of CROs and pharmaceutical organizations in the region are increasing in recent past due to low cost of labor and public and private funding offered in countries such as India and China. However, inaccessibility of trial protocols and poor quality of registered clinical trial data, results, and participant-level data undermined the potential benefits of clinical trial registration earlier. Nevertheless, emergence of national and regional registries and ICTRP have facilitated to overcome aforementioned barriers in APAC.
Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/clinical-trial-imagingmarket
Follow Us:
Further key findings from the report suggest North America dominated the market in 2017. Attaining compliance with registration requires a combination of international and local measures and remains a key challenge in many countries. However, U.S. FDA and other regulatory organizations have played a leading role in attaining accomplishments of trial registration to date and is likely to be supported in tackling such challenges in the near future
Some of the players operating in this market are Parexel International Corporation; Intrinsic Imaging; Radiant Sage; Icon PLC; Worldcare Clinical; Bioclinica Inc.; Navitas Life Sciences; Resonance Health; Ixico PLC; and Medpace.
Grand View Research has segmented the global clinical trial imaging market based on service, modalities, end-use, and region: Clinical Trial Imaging Service Outlook (Revenue, USD Million, 2014 - 2026) Clinical trial design and consultation services
Reading and analytical Services
Operational Imaging services
System and technology support services
Project and Data Management
Clinical Trial Imaging Modalities Outlook (Revenue, USD Million, 2014 - 2026) Computed Tomography (CT) Scan
MRI ( Magnetic Resonance Imaging)
X-Ray
Ultrasound
Optical Coherence Tomography (OCT)
Others (Positron Emission Tomography (PET), Single-Photon Emission Computerized Tomography (SPECT)Reading and analytical Services
Clinical Trial Imaging End-use Outlook (Revenue, USD Million, 2014 - 2026) Biotechnology and Pharmaceutical companies
Medical Devices Manufacturers
Academic and government research institutes
Contract Research Organization (CROs)
Others (Cosmetics and skin care industries)
Clinical Trial Imaging Regional Outlook (Revenue, USD Million, 2014 - 2026) North America
o
U.S.
o
Canada
Europe
Follow Us:
o
U.K.
o
Germany
Asia Pacific o
India
o
China
Latin America o
Brazil
o
Mexico
Middle East & Africa o
South Africa
o
Saudi Arabia
Table of Content Chapter 1 Report Scope 1.1 Segment Market Scope 1.2 Regional Scope 1.3 Estimates and Forecast Timeline Chapter 2 Methodology 2.1 Research Methodology 2.1.1 Information procurement 2.2 Information or Data Analysis 2.3 Market Formulation & Validation 2.4 Region Wise Market Calculation 2.4.1 Region Wise Market: Base Estimates 2.4.2 Global Market: CAGR Calculation 2.5 Region Based Segment Share Calculation 2.6 Model Details 2.6.1 Commodity flow analysis (Model 1) 2.6.2 Volume price analysis (model 2) 2.7 List of Secondary Sources 2.8 List of Primary Sources 2.9 List of Abbreviations Chapter 3 Objectives
Follow Us:
3.1 Objective - 1: Understanding the market dynamics 3.2 Objective - 2: Understanding the market estimates and forecasts 3.3 Objective - 3: Understanding the attributes such as strategy framework, competitor categorization 3.4 Objective - 4: Understanding the key end-users, technological, application and product scopes Continue………….. About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market y provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and factbased research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email:sales@grandviewresearch.com For More Information:http://www.grandviewresearch.com
Follow Us: